PER-1-type extended-spectrum β-lactamase-producing Acinetobacter baumannii clinical isolates from India

International Journal of Antimicrobial Agents

Volumn 34, Issue 4, 2009, Pages 388-389

  Litake, Geetanjali M ^a,b   Ghole, Vikram S ^a   Niphadkar, Krishna B ^b   Joshi, Suresh G ^a,b  

^a UNIVERSITY OF PUNE   (India)

^b KEM HOSPITAL   (India)

Author keywords

Acinetobacter; DDST; ESBL; PCDDT; PER 1; Tracheal aspirates

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; BETA LACTAMASE PER 1; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFEPIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; INDIA; LETTER; MOLECULAR PHYLOGENY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TRACHEAL ASPIRATION PROCEDURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; HUMANS; INCIDENCE; INDIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA;

EID: 67651202323     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.06.006     Document Type: Letter

References (7)

1. Joshi S.G., Litake G.M., Niphadkar K.B., and Ghole V.S. Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 9 (2003) 187-190
2. Yong D., Shin J.H., Kim S., Lim Y., Yum J.H., Lee K., et al. High prevalence of PER-1 extended-spectrum β-lactamase-producing Acinetobacter spp. in Korea. Antimicrob Agents Chemother 47 (2003) 1749-1751
3. PER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 57 (2006) 975-978
4. Shukla I., Tiwari R., and Agrawal M. Prevalence of extended spectrum β-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Indian J Med Microbiol 22 (2004) 87-91
5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disc susceptibility tests; approved standard. 8th ed. Document M2-A8. Wayne, PA: CLSI; 2003.
6. Capoor M.R., Nair D., Srivastava L., Gupta B., and Aggarwal P. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup. J Commun Dis 37 (2005) 99-107
7. Naas T., Bogaerts P., Bauraing C., Degheldre Y., Glupczynski Y., and Nordmann P. Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother 58 (2006) 178-182